Early Results Using Donor-Derived Marrow Infiltrating Lymphocytes (ddMILs) for Relapsed Disease after Allografting with Post-Transplant Cyclophosphamide (PTCy)

MLA

Ivana Gojo, et al. “Early Results Using Donor-Derived Marrow Infiltrating Lymphocytes (DdMILs) for Relapsed Disease after Allografting with Post-Transplant Cyclophosphamide (PTCy).” Biology of Blood and Marrow Transplantation, vol. 25, Mar. 2019, p. S239. EBSCOhost, https://doi.org/10.1016/j.bbmt.2018.12.234.

APA

Ivana Gojo, Amy E. DeZern, Vic Lemas, Ivan Borrello, Janice M. Davis-Sproul, Kim Noonan, Laura Schoch, Douglas E. Gladstone, Laura Cucci, Gabrielle T. Prince, Carol Ann Huff, Leo Luznik, Richard F. Ambinder, Richard J. Jones, & Syed Abbas Ali. (2019). Early Results Using Donor-Derived Marrow Infiltrating Lymphocytes (ddMILs) for Relapsed Disease after Allografting with Post-Transplant Cyclophosphamide (PTCy). Biology of Blood and Marrow Transplantation, 25, S239. https://doi.org/10.1016/j.bbmt.2018.12.234

Chicago

Ivana Gojo, Amy E. DeZern, Vic Lemas, Ivan Borrello, Janice M. Davis-Sproul, Kim Noonan, Laura Schoch, et al. 2019. “Early Results Using Donor-Derived Marrow Infiltrating Lymphocytes (DdMILs) for Relapsed Disease after Allografting with Post-Transplant Cyclophosphamide (PTCy).” Biology of Blood and Marrow Transplantation 25 (March): S239. doi:10.1016/j.bbmt.2018.12.234.